Canada’s generic pharmaceutical industry continues to play a critical role in maintaining affordable access to medicines, supporting pharmacy supply chains and strengthening domestic pharmaceutical capabilities. In 2026, the competitive landscape is being shaped not only by conventional generics, but also by complex generics, biosimilars, sterile injectables, specialty medicines, product launches and supply-resilience initiatives. The companies...
Takeaways: PixCell Medical’s Health Canada license and distribution partnership with Inter Medico give HemoScreen a direct route into Canada’s growing point-of-care diagnostics market, particularly hospitals, community clinics, oncology centers, and rural or remote settings. Its portable, maintenance-free design could help providers perform rapid 5-part CBC testing closer to patients, while expanding access to decentralized hematology testing and strengthening PixCell’s position in the Canadian...
